Genital herpes: Management issues for the next century

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue SUPPL.1, 1997, Pages 45-50

  Sacks, S L ^a   Wilson, B R ^b  

^a Viridae Clinical Sciences Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diagnosis; Genital herpes; Prevention; Psychosocial outcomes; Symptoms

Indexed keywords

ACICLOVIR; FAMCICLOVIR; VALACICLOVIR; ANTIVIRUS AGENT;

CLINICAL FEATURE; CONFERENCE PAPER; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INFECTION RISK; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; VIRUS TRANSMISSION; RECURRENCE RISK; RECURRENT VIRUS INFECTION; VIRUS SHEDDING;

EID: 0031469907     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/09563202970080s610     Document Type: Conference Paper

References (34)

1. Aurelius E, Johansson B, Skoldenberg B, Staland A & Forsgren M (1991) Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337: 189-192.
2. Benedetti J, Corey L & Ashley R (1994) Recurrence rates in genital herpes after symptomatic first-episode infection. Annals of Internal Medicine 121: 847-854.
3. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ & Ho M (1990) Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infection. Journal of Infectious Diseases 162: 299-305.
4. Caplan LR, Kleeman FJ & Berg S (1977) Urinary retention probably secondary to herpes genitalis. New England Journal of Medicine 297: 920-921.
5. Cone RW, Hobson AC, Palmer J, Remington M & Corey L (1991) Extended duration of herpes simplex DNA in genital lesions as detected by the polymerase chain reaction. Journal of Infectious Diseases 164: 757-760.
6. Cone RW, Swenson PD, Hobson AC et al. (1993) Herpes simplex virus detection from genital lesions: a comparative study using antigen detection (HerpChek) and culture. Journal of Clinical Microbiology; 31: 1774-1776.
7. Corey L (1990) Genital herpes. In Sexually Transmitted Diseases. Edited by Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, Cates W Jr, Lemon SM & Stamm WE, pp. 391-415, New York: McGraw-Hill.
8. Corey L, Adams HG, Brown ZA & Holmes KK (1983) Genital herpes simplex virus infections: Clinical manifestations, course and complications. Annals of Internal Medicine 98: 958-972.
9. Corey L & Spear PG (1986) Infections with herpes simplex viruses. New England Journal of Medicine 314: 686-691.
10. Corey L & Wald A (1995) New developments in the biology of genital herpes. In Clinical Management of Herpes Viruses. Edited by Sacks SL, Straus SE, Whitley RJ, Griffiths PD, pp. 43-53, Amsterdam: IOS Press.
11. Farrel HE, McClean CS, Harley C, Efstathiou S, Inglis S & Minson AC (1994) Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. Journal of Virology 68: 927-932.
12. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK & St Louis ME (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. New England Journal of Medicine 337: 1105-1111.
13. Goldberg LH, Kaufman R, Kurtz TO, Conant MA, Eron LJ, Batenhorst RL, Boone GS & the Acyclovir Study Group (1993) Long-term suppression of recurrent genital herpes with acyclovir. Archives of Dermatology 129: 582-587.
14. Jones TJ & Paul P (1995) Disseminated acycolvir-resistant herpes simplex virus type 2 treated successfully with foscarnet. Journal of Infectious Diseases 171: 508-509.
15. Kalinyak JE, Fleagle G & Docherty JJ (1977) Incidence and distribution of herpes simplex virus types 1 and 2 from genital lesions in college women. Journal of Medical Virology 1: 173.
16. Kinghorn GI & Fiddian AP (1995) The International Valaciclovir HSV Study Group. Prevention of lesion development in recurrent genital herpes with oral valaciclovir [abstract P187]. Journal of the European Academy of Dermatology and Venereology 5 (Supplement 1): S162.
17. Kost RG, Hill EL, Tigges M & Straus SE (1993) Brief Report: Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. New England Journal of Medicine 329: 1777-1782.
18. Mertz G (1993) Epidemiology of genital herpes infections. Infectious Disease Clinics of North America 7: 825-839.
19. Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, Redfield DC, Savoia MC, Richman DD, Tyrell DL, Miedzinski L, Portnoy J & Keeney RN (1984) Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. Journal of the American Medical Association 252: 1147-1151.
20. Mertz GJ, Coombs RW, Ashley RL, Jourden J, Remington M, Winter C, Fahnlander A, Guinan M, Ducey H & Corey L (1988) Transmission of genital herpes in couples with one symptomatic partner and one asymptomatic partner: a prospective study. Journal of Infectious Diseases 157: 1169-1177.
21. Morrison LA & Knipe DM (1994) Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. Journal of Virology 68: 689-696.
22. Nahmias AJ, Lee FK & Bechman-Nahmias S (1990) Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scandinavian Journal of Infectious Diseases 69: 19.
23. Parris DS & Harrington JE (1982) Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrobial Agents and Chemotherapy 22: 71-77.
24. Pottage JD Jr & Kessler KA (1995) Herpes simplex virus resistance to acyclovir: clinical relevance. Infectious Agents and Diseases 4: 115-124.
25. Riehle RA & Williams JJ (1979) Transient neuropathic bladder following herpes simplex genitalis. Journal of Urology 122: 263-264.
26. Rooney JJ, Felser JM, Ostrove JM & Straus SE (1986) Acquisition of genital herpes from an asymptomatic sexual partner. New England Journal of Medicine 314: 1561-1564.
27. Sacks S (1995) Genital herpes simplex virus infection and treatment. In Clinical Management of Herpes Viruses. Edited by Sacks SL, Straus SE, Whitley RJ, Griffiths PD. Amsterdam, Netherlands: IOS Press, pp55-74.
28. Safrin S, Arvin A, Mills J & Ashley R (1992) Comparison of the western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. Journal of Clinical Microbiology 30: 1312-1314.
29. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K & Valaciclovir Study Group (1996) A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Archives of Internal Medicine 156: 1729-1735.
30. Stanberry LR (1991) Subunit viral vaccines: prophylactic and therapeutic use. In: Herpesviruses, the Immune System, and AIDS. Edited by Aurelian L, pp. 309-341, Boston: Kluwer Academic Publishers.
31. Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, Kost RG, Meier JL, Sekulovich R, Adair SF & Dekker CL (1994) Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343: 1460-1463.
32. Wald A, Zeh J, Selke S, Ashley RL & Corey L (1995) Virologic characteristics of subclinical and symptomatic genital herpes infections. New England Journal of Medicine 333: 770-775.
33. Wald A, Zeh J, Barnum G, Davis LG & Corey L (1996) Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Annals of Internal Medicine 124: 8-15.
34. Whitley RJ & Roizman B (1997) Herpes simplex viruses. In Clinical Virology. Edited by Richman DD, Whitley RJ & Hayden FG. New York: Churchill Livingstone, pp375-410.